Stock A214390 KYONGBO PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Total Return chart Kyongbo Pharmaceutical Co., Ltd

Equities

A214390

KR7214390007

End-of-day quote Korea S.E.
Other stock markets
 04:30:00 27/03/2024 am IST 		5-day change 1st Jan Change
7,440 KRW -2.75% Intraday chart for Kyongbo Pharmaceutical Co., Ltd -.--% -11.32%
2023 Pharosgen Co., Ltd. announced that it has received KRW 1.999997692 billion in funding from Kyongbo Pharmaceutical Co., Ltd CI
2023 Kyongbo Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

Past dividends on Kyongbo Pharmaceutical Co., Ltd

27/12/2023 Annual 50 KRW
28/12/2022 Annual 50 KRW
29/12/2021 Annual 50 KRW
29/12/2020 Annual 100 KRW
27/12/2019 Annual 100 KRW
27/12/2018 Annual 200 KRW
27/12/2017 Annual 250 KRW
28/12/2016 Annual 200 KRW
29/12/2015 Annual 275 KRW
  1. Stock Market
  2. Equities
  3. A214390 Stock
  4. Charts Kyongbo Pharmaceutical Co., Ltd
  5. Total Return chart